康美药业 (600518.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

54.0x

Market Cap

CNY 18.53B

MomentumView details →

1D Return

−1.47%

YTD Return

−27.75%

RSI (14)

49.9

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

54.0x

Market Cap

CNY 18.53B

RSI (14)

49.9

MomentumView details →

1D Return

−1.47%

YTD Return

−27.75%

ProfitabilityView details →

Gross Margin

20.90%

Net Margin

−0.29%

EBITDA Margin

6.63%

ROE (TTM)

−0.20%

ROA (TTM)

−0.11%

Asset Turnover

0.38x

GrowthView details →

Revenue YoY

−4.81%

EPS YoY

—

FCF YoY

+73.11%

Revenue CAGR 3Y

+7.91%

EPS CAGR 3Y

−73.54%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.02x

Current Ratio

1.27x

Quick Ratio

0.82x

Div Yield

—

Div Rate

—

Div Growth 1Y

−89.79%

Financials snapshotView financials →

Revenue (TTM)

5.03B

Net Income (TTM)

−14.74M

Op. CF (TTM)

157.98M

Latest newsMore news →

Kangmei Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 36.0348 million yuan, up 113.21% year-on-year, while revenue fell 11.13% to 2.29 billion yuan.10d ago

Kangmei Pharmaceutical's chairman Lai Zhijian resigned from his positions as chairman, director, and legal representative, and Ou Guoxiong was appointed to act as chairman and legal representative.14d ago

Similar companies

西藏药业600211.SH 益丰药房603939.SH 同仁堂600085.SH 老百姓603883.SH BeOne Medicines Ltd.ONC 奥锐特605116.SH Find similar companies →

Latest newsMore news →

Kangmei Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 36.0348 million yuan, up 113.21% year-on-year, while revenue fell 11.13% to 2.29 billion yuan.10d ago Kangmei Pharmaceutical's chairman Lai Zhijian resigned from his positions as chairman, director, and legal representative, and Ou Guoxiong was appointed to act as chairman and legal representative.14d ago